Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02900560 |
| Title | Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Translational Research in Oncology |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |